Authors
Latest:
An Overview of ArgyriaArgyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Latest:
Managing aBCC and aCSCC With Cemiplimab: Tips From Matthew Reynolds, PA-CReynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.
Latest:
Modern Dermatology: Advanced Meds and Social Media MythsRob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.
Latest:
Phase 2b Trial Reinforces Zasocitinib’s Safety ProfileMelinda Gooderham, MSc, MD, FRCPC, emphasized the significance of the study’s results, showcasing stable laboratory parameters over a 12-week trial.
Latest:
Telehealth in 2023: What Physicians Need to KnowAnswers to some common questions about providing telehealth services in 2023.
Latest:
Final Thoughts on Tapinarof in AD Clinical TrialsRaj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, review the study results for the ADORING 1 and ADORING 2 trials, as well as share closing thoughts on the use of tapinarof in management of AD.
Latest:
Glynis Ablon, MD, Previews IMCAS World Congress 2024Ablon’s session highlights include best practices for hair restoration.
Latest:
Shedding LITE on At-Home Phototherapy Treatment for PsoriasisGet a sneak peek ahead of AAD about the LITE study’s patient-centered design, routine care integration, and diverse participant inclusion, offering a cost-effective option in psoriasis treatment.
Latest:
Promoting Diversity and Acceptance Through Positive ExposureRick Guidotti, fashion photographer turned patient advocate, discusses reframing beauty through his nonprofit Positive Exposure.
Latest:
Examining Molecular Differences in PDE4 Inhibitors in Pediatric Patients with Plaque PsoriasisPanelists discuss how the two approved PDE4 inhibitors for pediatric plaque psoriasis differ in their systemic treatments, highlighting key differences in efficacy, safety profiles, and patient considerations for optimal use.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Optimizing Plaque Psoriasis Treatment in a 32-Year-Old Man: Addressing Genital Plaques for Improved Patient Comfort and OutcomesPanelists discuss how to optimize plaque psoriasis treatment in a 32-year-old man, with a specific focus on addressing genital plaques to enhance patient comfort and improve overall treatment outcomes.
Latest:
Beyond Aesthetics: The Vital Role of Nails in HealthMartin Zaiac, MD, gave insight on potential risks associated with manipulation of nails, hygiene, and when it is necessary to see a specialist.
Latest:
Rosacea Treatment: Letting the Patient Lead the WayHilary Baldwin, MD, emphasized involving patients in the decision-making process to create a personalized and cost-effective plan.
Latest:
Topical Remetinostat Effective, Tolerable in Basal Cell CarcinomaThe topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.
Latest:
Residency Is Ending Soon: Key Financial Tips for Your Next ChapterFrom a financial perspective, the change from resident to attending dermatologist may be profound.
Latest:
Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.
Latest:
Navigating Challenges and Advancements in Alopecia Areata TreatmentMaryanne Makredes Senna, MD, shares insights into the complexities of treating alopecia areata and guidance for clinicians.
Latest:
Severity of Psoriatic Disease Significantly Associated With Risk of Inflammatory Bowel DiseaseA recent study identified an association between psoriasis severity and IBD, Crohn disease, and ulcerative colitis.
Latest:
Tips for Difficult to Control Chronic Spontaneous UrticariaAmanda L. Michaud, PA-C, shares insights on difficult to control chronic spontaneous urticaria at the ACAAI Annual Scientific Meeting.
Latest:
New Long-Term KEYNOTE-716 Data Presented at ASCO 2023Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.
Latest:
Cancer Vaccine Plus Keytruda Improves Survival Without Relapse in Resected MelanomaFindings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma.
Latest:
Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin AcademyLópez-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Latest:
Autologous Fat Grafting Proves Promising in Treatment of Cicatricial AlopeciaAutologous fat grafting may be able to treat alopecia by controlling inflammation, enhancing symptoms, and boosting hair density.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
